Microsoft India launches AI eyecare research network

success. Other areas they will look at include the rate of change of myopia in children, conditions that impact children's eyesight and predictive outcomes of refractive surgery.

Lucentis claims speedy FDA review for myopia complication

The US FDA has said it will use its six-month review process for Roche's Lucentis as a treatment for choroidal neovascularization in patients with severe near-sightedness (myopia).

Bayer files eye drug Eylea for new use in EU

Meanwhile, it has also been filed in Europe for the treatment of diabetic macular oedema and in Japan for choroidal neovascularisation caused by pathologic myopia (mCNV).

Novartis licenses Ophthotech eye drug in $1bn deal

Novartis already sells anti-VEGF (vascular endothelial growth factor) drug Lucentis (ranibizumab) for wet AMD - as well as other indications such as pathological myopia and macular oedema - and achieved sales of

NICE backs two eye treatments

The Lucentis guidance covers the use of the medicine to treat sight problems caused by choroidal neovascularisation (CNV) in people with a rare form of short-sightedness known as pathological myopia. ... Pathological myopia is a chronic form of myopia,

Marketing

Multichannel in pharma

Go beyond multichannel rep myopia: include stakeholders beyond target HCPs. Invest in marketing technology and high-quality data.